Variant survivin vaccine for treatment of myeloma Grant US-11149072-B2 United States of America 19 Oct 2021
Oligomeric compounds for the modulation of survivin expression Grant US-8026355-B2 United States of America 27 Sep 2011
Oligomeric compounds for the modulation of survivin expression Grant US-7741309-B2 United States of America 22 Jun 2010